GIP and obesity due to melanocortin 4 receptor deficiency: However, it remains unclear whether pharmacological concentrations of GIP can induce similar pro-inflammatory changes, or conversely suppress the inflammation because both physiological GIP inhibition and pharmacological GIP administration can similarly induce anti-obesity effects [46,47,48,49,50,52].